Back
Jasper Therapeutics Stock Predictions
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
62
JSPR
Jasper Therapeutics
Last Price:
$6.00
Seasonality Move:
-15.34%
7 Day Trial
ALL ACCESS PASS
$
7
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteJasper Therapeutics Stock Forecast
-
Over the next 52 weeks, Jasper Therapeutics has on average historically fallen by 26.8% based on the past 5 years of stock performance.
-
Jasper Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Jasper Therapeutics Stock Undervalued?The current Jasper Therapeutics [JSPR] share price is $5.94. The Score for JSPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
JSPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Jasper Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Jasper Therapeutics has on average historically fallen by 26.8% based on the past 5 years of stock performance.
Jasper Therapeutics Stock Rating
Buy
62
Jasper Therapeutics (JSPR)
is a Buy
Is Jasper Therapeutics overpriced?
-
Jasper Therapeutics has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Jasper Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
jaspertherapeutics.com
52-Week Data
52-Week High:
26.05
52-Week Low:
3.13
Prediction Charts
Market Cap:
89.2M
Price in USD:
5.94
Volume:
220K
Beta:
2.13
Technical Analysis
SMA50:
4.74
SMA100:
5.24
SMA200:
12.80
52-Wk Change:
-75.77%
Stock Predictions
-
Is Jasper Therapeutics stock public?Yes, Jasper Therapeutics is a publicly traded company.
-
What is the Jasper Therapeutics stock quote today?The Jasper Therapeutics stock price is 5.94 USD today.
-
How to buy Jasper Therapeutics stock online?You can buy Jasper Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-20 | 5.00 | 5.04 | 5.11 | 4.96 |
| May-21 | 5.03 | 4.82 | 5.09 | 4.57 |
| May-22 | 4.81 | 4.87 | 4.96 | 4.72 |
| May-23 | 4.81 | 4.77 | 4.90 | 4.72 |
| May-27 | 4.91 | 4.77 | 4.95 | 4.71 |
| May-28 | 4.76 | 5.11 | 5.39 | 4.71 |
| May-29 | 5.19 | 5.68 | 5.90 | 5.16 |
| May-30 | 5.62 | 5.50 | 5.80 | 5.23 |
| Jun-2 | 5.56 | 5.45 | 5.62 | 5.25 |
| Jun-3 | 5.47 | 5.90 | 6.20 | 5.46 |
| Jun-4 | 5.96 | 6.00 | 6.15 | 5.76 |
| Jun-5 | 6.00 | 5.70 | 6.03 | 5.56 |
| Jun-6 | 5.84 | 6.01 | 6.02 | 5.67 |
| Jun-9 | 6.05 | 5.94 | 6.10 | 5.86 |
Jasper Therapeutics Earnings
Jasper Therapeutics Earnings Report: Per Share Jasper Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Jasper Therapeutics Forecast Revenue Growth
Jasper Therapeutics Stock Analysis: Historical quarterly revenues per share for Jasper Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.91 per share, and an increase next year of $0.21 per share.
* Jasper Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.